Corcept Therapeutics Incorporated (CORT) analyst actions
Rating and price-target actions on CORT in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CORT overview →
6 measured CORT analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Corcept Therapeutics Incorporated (CORT) And Encourages Shareholders to Reach Out | Press release | +0.34% | +3.46% | |
| Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer | Press release | -2.88% | +2.73% | |
| Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension | Press release | +1.73% | +5.22% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Corcept Therapeutics Incorporated (CORT) And Encourages Shareholders to Reach Out | Press release | +1.73% | +5.22% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Corcept Therapeutics Incorporated (CORT) And Encourages Stockholders to Reach Out | Press release | +0.49% | -0.02% | |
| Corcept Initiates MONARCH – A Phase 2b Trial in Non-Alcoholic Steatohepatitis (NASH) | Press release | -0.22% | -1.12% |
Keep exploring
More CORT: earnings → · SEC filings → · CORT overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| WRIGHT MEDICAL GROUP NV (WMGI) | 1,168 | -0.07% | 42% |
| Acadia Healthcare Company, Inc. (ACHC) | 1,165 | -0.02% | 49% |
| Medpace Holdings, Inc. (MEDP) | 1,147 | -0.01% | 50% |
| Epizyme, Inc. (EPZM) | 1,145 | +0.04% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.